QQQ 308.76 (-0.69%)

AAPL 158.28 (-1.23%)

MSFT 276.38 (-1.49%)

META 202.84 (-1.54%)

GOOGL 102.46 (-2.83%)

AMZN 98.04 (-0.09%)

TSLA 191.81 (+0.74%)

NVDA 265.31 (-0.93%)

NIO 8.93 (-1.54%)

BABA 86.12 (-0.90%)

AMD 96.61 (-1.37%)

T 18.87 (+1.40%)

F 11.52 (+0.09%)

MU 59.79 (-2.24%)

CGC 1.88 (-1.05%)

GE 93.31 (+2.12%)

DIS 95.62 (+1.64%)

AMC 4.55 (+1.79%)

PFE 40.22 (-0.42%)

PYPL 73.30 (-0.79%)

NFLX 327.66 (-0.22%)

QQQ 308.76 (-0.69%)

AAPL 158.28 (-1.23%)

MSFT 276.38 (-1.49%)

META 202.84 (-1.54%)

GOOGL 102.46 (-2.83%)

AMZN 98.04 (-0.09%)

TSLA 191.81 (+0.74%)

NVDA 265.31 (-0.93%)

NIO 8.93 (-1.54%)

BABA 86.12 (-0.90%)

AMD 96.61 (-1.37%)

T 18.87 (+1.40%)

F 11.52 (+0.09%)

MU 59.79 (-2.24%)

CGC 1.88 (-1.05%)

GE 93.31 (+2.12%)

DIS 95.62 (+1.64%)

AMC 4.55 (+1.79%)

PFE 40.22 (-0.42%)

PYPL 73.30 (-0.79%)

NFLX 327.66 (-0.22%)

QQQ 308.76 (-0.69%)

AAPL 158.28 (-1.23%)

MSFT 276.38 (-1.49%)

META 202.84 (-1.54%)

GOOGL 102.46 (-2.83%)

AMZN 98.04 (-0.09%)

TSLA 191.81 (+0.74%)

NVDA 265.31 (-0.93%)

NIO 8.93 (-1.54%)

BABA 86.12 (-0.90%)

AMD 96.61 (-1.37%)

T 18.87 (+1.40%)

F 11.52 (+0.09%)

MU 59.79 (-2.24%)

CGC 1.88 (-1.05%)

GE 93.31 (+2.12%)

DIS 95.62 (+1.64%)

AMC 4.55 (+1.79%)

PFE 40.22 (-0.42%)

PYPL 73.30 (-0.79%)

NFLX 327.66 (-0.22%)

QQQ 308.76 (-0.69%)

AAPL 158.28 (-1.23%)

MSFT 276.38 (-1.49%)

META 202.84 (-1.54%)

GOOGL 102.46 (-2.83%)

AMZN 98.04 (-0.09%)

TSLA 191.81 (+0.74%)

NVDA 265.31 (-0.93%)

NIO 8.93 (-1.54%)

BABA 86.12 (-0.90%)

AMD 96.61 (-1.37%)

T 18.87 (+1.40%)

F 11.52 (+0.09%)

MU 59.79 (-2.24%)

CGC 1.88 (-1.05%)

GE 93.31 (+2.12%)

DIS 95.62 (+1.64%)

AMC 4.55 (+1.79%)

PFE 40.22 (-0.42%)

PYPL 73.30 (-0.79%)

NFLX 327.66 (-0.22%)

Ad Behind the Markets 4,122 Recent Views

BREAKING: Tiny biotech successfully treats blindness

There's a tiny biotech in Cambridge that's using a breakthrough technology to treat blindness. This company has already shown success in human trials... And Our research shows that anyone who gets in today could see a 46,751% return.

Get the Details Here >>>

Stock Market News

ex-dividend date stocks

ex-dividend date stocks

Should You Buy Before the Ex-Dividend Date or Wait?

Whether you're a newcomer to the world of dividend stocks or a veteran, the question of whether to buy before the ex-dividend date will always be one to ponder. Buying a dividend stock before the ex-dividend date seems evident since you would be entitled to receive the dividend. However, if you understand what happens when a dividend is distributed, the answer gets more involved. New dividend investors mistakenly believe that a dividend is a free money for shareholders. It's a way of getting income from holding dividend stocks. That…

dividend stocks to buy

dividend stocks to buy

Dividends, Short-Term Pain, but Long-Term Gain?

Dividend stocks drop by the dividend amount on the ex-dividend date. The stock takes a short-term hit, but the shareholders are compensated in cash on the payout date. If it's a wash, why are there so many dividend investors? Simple. Dividend investors seek income from holding their stocks long-term. They don't feel they lose anything because they are getting paid the dividend, and the short-term price drop will eventually be recovered if they hold the stock long enough. Well, that may only sometimes be the case. Benchmark Indexes Rise…

Carnival Cruise lines stock price

Carnival Cruise lines stock price

Can Carnival Cruise Lines Set Sail For New Highs?

Carnival Cruise Lines (NYSE: CCL) has been weathering stormy seas for the last 2 years, but the skies are clearing, and smoother sailing is ahead. The headwinds are not over, but signs within the Q1 earnings report point to a return to normalcy that includes positive cash flow and debt reduction. What this means for investors is a chance to buy this stock at the lowest prices it has seen in 20 years and at an 80% discount to its prepandemic price point. The Bad Times Are Behind Carnival Cruise Lines The signal in the results…

BioNTech stock price

BioNTech stock price

BioNTech Is Ripe For A Rebound In 2023

BioNTech (NASDAQ: BNTX) got a substantial boost from the pandemic and its mRNA vaccine, developed with Pfizer (NYSE: PFE). The stock has seen a substantial correction since then due to slowing COVID sales, but the bottom is in. While COVID sales have slowed, this company is not dependent on COVID for its bread and butter and is set up for a rebound in 2023. Not only does it have a growing pipeline of drugs and candidates in the pipeline advancing toward approval, but there are factors in play that make it a potential takeover target…

Used medical syringes on blue tone

Used medical syringes on blue tone

Sanofi, Regeneron Shares Pop On Big News About COPD Treatment

Shares of Sanofi (NASDAQ: SNY) were up 10.20% the week ended March 24, while Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) finished with a gain of 9.68%, following promising news about the companies’ jointly developed medication Dupixent. In Phase 3 clinical trials, Dupixent reduced severe flare-ups of chronic obstructive pulmonary disease (COPD) at a far better rate than a placebo. In a joint news release, the companies said, “Dupixent is the first and only biologic to demonstrate a clinically meaningful and highly…

Latest Stock Market News

Free Email Newsletter

Sign up to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter:

Sector Performance

Sector Performance Map

Ad Weiss Ratings

Bank Accounts: Frozen!

In 1990, the Brazilian government froze the bank accounts of thousands of citizens. In 2013, the victims were the people of Cyprus. In 2022, it hit closer to home — in Canada. And now the Federal Reserve System Docket No. OP-1670 reveals the plan to give the Fed the power to track and potentially even control your checking account. Not just the money you have in your account … But also, every single check, withdrawal, deposit and transaction. Practically everything you do with your money!

Find out how to protect yourself here

Popular Articles

Dividend contenders stocks

Dividend contenders stocks

1+ days ago | March 22nd | 2023 7:00AM

3 Dividend Contenders to Buy Now for Long-Term Gains Later

Stock Ideas

High Yield Stocks

High Yield Stocks

9 hours ago | March 27th | 2023 2:30PM

3 High Yields On Breakout Watch With Analyst Tailwinds

Instant Alerts

1 hour ago | March 27th | 2023 10:37PM

Bank of America Raises Amicus Therapeutics (NASDAQ:FOLD) Price Target to $17.00

Free Stock Analysis Report: Get Buy, Sell, or Hold Recommendation

Get a full report that tells you what a stock is really worth, how safe the stock is, and if the timing is right to buy the stock. Plus a definitive Buy, Sell, Hold recommendation.

Analyze Any Stock Free

Popular Stocks

Company	Current Price	Price Change
AAPL Apple Inc.	$158.28	-1.23%
MSFT Microsoft Co.	$276.38	-1.49%
META Meta Platforms, Inc.	$202.84	-1.54%
GOOGL Alphabet Inc.	$102.46	-2.83%
AMZN Amazon.com, Inc.	$98.04	-0.09%
TSLA Tesla, Inc.	$191.81	0.74%
NVDA NVIDIA Co.	$265.31	-0.93%
NIO Nio Inc -	$8.93	-1.54%
BABA Alibaba Group Holding Limited	$86.12	-0.90%
AMD Advanced Micro Devices, Inc.	$96.61	-1.37%
T AT&T Inc.	$18.87	1.40%
F Ford Motor	$11.52	0.09%
MU Micron Technology, Inc.	$59.79	-2.24%

Analyst Ratings

Company	Brokerage	Action
SLG SL Green Realty Corp.	Citigroup	Lower Price Target $35.00 ➝ $17.00
JOAN JOANN Inc.	Bank of America	Lower Price Target $3.50 ➝ $1.00
BNTX BioNTech SE	Bank of America	Lower Price Target $239.00 ➝ $194.00
FOLD Amicus Therapeutics, Inc.	Bank of America	Boost Price Target $16.00 ➝ $17.00
LULU Lululemon Athletica Inc.	Barclays	Lower Price Target $394.00 ➝ $368.00
PSN Parsons Co.	William Blair	Upgrade to Outperform
GMDA Gamida Cell Ltd.	Oppenheimer	Lower Price Target $10.00 ➝ $8.00
GERN Geron Co.	The Goldman Sachs Group	Initiated Coverage at Neutral
RGEN Repligen Co.	Benchmark	Initiated Coverage at Buy
BOWL Bowlero Corp.	Stifel Nicolaus	Initiated Coverage at Buy
CARR Carrier Global Co.	Oppenheimer	Initiated Coverage at Outperform
LII Lennox International Inc.	Oppenheimer	Initiated Coverage at Market Perform

See All Analyst Ratings

Today's Top Gainers

Company	Price Change	Indicator
EVCI EVCI Career Colleges Holding Corp.	146.15%	News Coverage Gap Up
INNVD Innovus Pharmaceuticals Inc	143.90%	Gap Up
EJMLL Fantex, Inc.	100.00%	Gap Up
WISA WiSA Technologies, Inc.	89.47%	Short Interest ↓ High Trading Volume
CERPQ Cereplast, Inc.	64.65%	Gap Down High Trading Volume
CUENW Cuentas Inc.	60.00%	Positive News Gap Down High Trading Volume
UMLGF United Malt Group Limited	57.20%	Gap Up
CCTC Clean Coal Technologies, Inc.	53.85%	Short Interest ↓ Gap Up High Trading Volume
FCNCA First Citizens BancShares, Inc.	53.74%	Short Interest ↓ News Coverage Positive News Gap Up High Trading Volume
SRAX SRAX, Inc.	46.34%	Gap Up
LMAOU LMF Acquisition Opportunities, Inc.	41.59%	Gap Up High Trading Volume
GRRR Gorilla Technology Group Inc.	41.15%	News Coverage Positive News Gap Up High Trading Volume

See More Top Gainers

Today's Top Losers

Company	Price Change	Indicator
ESRCF ESR Group Limited	-84.03%	News Coverage Gap Down
CDAK Codiak BioSciences, Inc.	-56.75%	Upcoming Earnings Short Interest ↑ News Coverage Gap Down Trading Halted High Trading Volume
UBX Unity Biotechnology, Inc.	-53.01%	News Coverage Gap Down Trading Halted High Trading Volume
SPEC SpectralCast, Inc.	-50.65%	Gap Down
GMDA Gamida Cell Ltd.	-49.63%	Analyst Report Short Interest ↓ News Coverage Gap Down High Trading Volume
HCYTD H-CYTE, Inc.	-49.50%	Gap Down High Trading Volume
VRSRF Versarien plc	-48.48%	Gap Down
TNLX Trans-Lux Co.	-43.32%	Gap Down
ZURA Zura Bio Limited	-42.76%	Gap Up Trading Halted High Trading Volume
JATT JATT Acquisition Corp	-42.76%	Gap Up High Trading Volume
LTONY MNC Media Investment Ltd	-42.19%	Gap Down High Trading Volume
SONN Sonnet BioTherapeutics Holdings, Inc.	-41.04%	Short Interest ↓ Positive News Gap Down High Trading Volume

See More Top Losers

Web Analytics

Get 30 Days of MarketBeat All Access Free

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial